We are live on ! Find out more
NC

Nexthera Capital Portfolio holdings

AUM $120M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
+15.42%
1 Year Est. Return
+10.01%
3 Year Est. Return
+160.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$542M
AUM Growth
+$154M
Cap. Flow
+$142M
Cap. Flow %
26.23%
Top 10 Hldgs %
64.51%
Holding
60
New
22
Increased
12
Reduced
3
Closed
21

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$37.3M
2
MRK icon
Merck
MRK
+$20.1M
3
VTRS icon
Viatris
VTRS
+$18M
4
ABLX
Ablynx NV
ABLX
+$14.4M
5
SHPG
Shire pic
SHPG
+$13.7M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$20.3M
2
GSK icon
GSK
GSK
+$14.5M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$12.9M
4
ACRS icon
Aclaris Therapeutics
ACRS
+$10.7M
5
AKAO
Achaogen Inc
AKAO
+$9.21M

Sector Composition

Rank Sector Weight
1 Healthcare 48.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
51
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-184,680
Closed -$12.9M
ZSAN
52
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-537
Closed -$309K
FLXN
53
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-271,136
Closed -$6.64M
ALXN
54
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-62,337
Closed -$7.59M
AVEO
55
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-5,200
Closed -$190K
ARRY
56
DELISTED
Array Biopharma Inc
ARRY
– –
-615,437
Closed -$7.57M
AKAO
57
DELISTED
Achaogen Inc
AKAO
– –
-577,766
Closed -$9.21M
STDY
58
DELISTED
SteadyMed Ltd
STDY
– –
-258,918
Closed -$867K
IPXL
59
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-402,404
Closed -$8.17M
RXDX
60
DELISTED
Ignyta, Inc.
RXDX
– –
-285,728
Closed -$3.53M
1 2
3

Similar funds

KAM
Kavi Asset Management New York $121M AUM 7.54% 1-Year Est. Return
VCP
Vernier Capital Partners New York $132M AUM 20.75% 1-Year Est. Return
PFC
Personal Financial Consultants Lafayette, California $133M AUM 5.06% 1-Year Est. Return
FCA
Florence Capital Advisors New York $105M AUM
TA
TMD & Associates Scottsdale, Arizona $146M AUM 1.29% 1-Year Est. Return
EBIM
Eagle Boston Investment Management Boston, Massachusetts $87.3M AUM 4.18% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
ACP
ArcLight Capital Partners Boston, Massachusetts $83.2M AUM 32.11% 1-Year Est. Return

Nexthera Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Nexthera Capital held 60 positions worth $542M, up 40% from $389M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Nexthera Capital deployed $142M of net new capital in Q4 2017, opening 22 new positions and adding to 12 existing holdings. Its largest new stake was Allergan plc: 207,871 shares worth $34M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 50% a quarter earlier.

On the sell side, the largest reduction was Immunomedics Inc, an estimated $4.57M trimmed.

  • Nexthera Capital's largest Q4 2017 buy was Allergan plc: 207,871 shares worth $34M.
  • Nexthera Capital added most to Shire pic in Q4 2017, an estimated $13.7M increase.
  • Nexthera Capital's biggest Q4 2017 reduction was Immunomedics Inc, cutting an estimated $4.57M.
  • Nexthera Capital fully exited Seagen Inc. Common Stock in Q4 2017, selling an estimated $20.3M.
  • Nexthera Capital's ten largest holdings make up 65% of its $542M portfolio in Q4 2017.
  • Nexthera Capital opened 22 new positions and closed 21 in Q4 2017.
  • Nexthera Capital's portfolio value rose 40% quarter-over-quarter to $542M.

Based on Nexthera Capital's 13F filing for Q4 2017, filed 14 Feb 2018.